Paraneoplastic Raynaud's Phenomenon: A Case Report.
증례보고
1/5 보강
Raynaud's phenomenon is a vasospastic disorder that may occur as a primary benign condition or as a secondary manifestation of systemic disease.
APA
Vitó Madureira B, Aranha R, Soares Costa R (2025). Paraneoplastic Raynaud's Phenomenon: A Case Report.. Cureus, 17(12), e99075. https://doi.org/10.7759/cureus.99075
MLA
Vitó Madureira B, et al.. "Paraneoplastic Raynaud's Phenomenon: A Case Report.." Cureus, vol. 17, no. 12, 2025, pp. e99075.
PMID
41531633 ↗
Abstract 한글 요약
Raynaud's phenomenon is a vasospastic disorder that may occur as a primary benign condition or as a secondary manifestation of systemic disease. We describe the case of a 63-year-old man, with stage IV squamous cell carcinoma of the left lung undergoing palliative chemotherapy, who developed asymmetric and transient discoloration of the distal upper extremities. The patient's clinical history of active cancer, combined with exclusion of other secondary causes, supported a paraneoplastic etiology. Paraneoplastic Raynaud's phenomenon should be considered in adults with atypical or new-onset vasospastic symptoms, especially in the context of established malignancy. Early recognition is essential to optimize symptom management and enhance understanding of paraneoplastic vascular syndromes associated with lung cancer.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening.
- A herbal formulation inhibits growth and survival of lung cancer cells through DNA damage and apoptosis - in vitro and in vivo studies.
- Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategies.
- Lung Cancer Screening in Adults: State-of-the-Art and Policy Mapping (2025).
- Retrospective dosimetric evaluation of the collapsed cone, AAA, and Acuros XB algorithms for lung cancer Halcyon VMAT plans.
- Metastatic Pancreatic Adenocarcinoma with Germline BLM and Somatic ATM Mutations: A Case Report and Review of DNA Damage Response.